Anna Sureda MD PhD. Head of the Clinical Hematology Department, Institut Català d´ Oncologia-L’Hospitalet,  Barcelona, Spain. Anna Sureda is President of European Bone Marrow Transplantation Society (EBMT) and President of the Spanish Society for Stem Cell Transplantation and Cellular therapy (GETH-TC). She has occupied different leadership positions both in EBMT but also in CIBMTR (co-chair of the Lymphoma Committee till February 2019). She has focused her career on clinical investigations in the treatment of Hodgkin’s lymphoma, non-Hodgkin’s lymphoma and multiple myeloma patients evaluating novel therapies such as targeted therapies, immunotherapy and hematopoietic stem cell transplantation. She is the author and co-author of more than 400 publications related to the topic.